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ABSTRACT OF THESIS

COGNITION, REPETITIVE THOUGHT, AND SYSTEMIC INFLAMMATION
IN THE MIDLIFE IN THE UNITED STATES STUDY
Segerstrom et al. (2017) found that more repetitive thought (RT) was related to
lower interleukin-6 (IL-6), in older adults at average IQ. This study aimed to replicate
and extend this finding in midlife adults, with a daily measure of RT, and additional
inflammatory biomarkers. 153 participants were drawn from the Midlife in the United
States (MIDUS) Refresher project; ages 25-70 (M = 45.07, SD = 10.96), 50.3% female,
and 83% Caucasian. Cognition was assessed via the Brief Test of Adult Cognition by
Telephone, biological data via fasted blood draw, and RT data were collected as part of
the National Study of Daily Experiences daily diary. Total RT (amount one engages in
RT) and RT valence (positive vs. negative thought content) were analyzed. As IQ
increased, more positive RT was associated with lover levels of IL-6 and CRP after
adjusting for age, BMI, and statin use (b = -.161, p = .029; b = -.240, p = .002). Results
did not replicate Segerstrom et al. (2017) but suggested that crystallized intelligence and
RT total reflect a cognitive system different than that of fluid intelligence, executive
functioning, and RT valence. Future studies should continue to investigate effects of RT
on health outcomes.
KEYWORDS: repetitive thought, intelligence, IL-6, inflammation, MIDUS, cognition
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CHAPTER ONE: INTRODUCTION
Poor cognitive abilities may contribute to higher risk of smoking, being obese,
higher blood pressure, higher risk for psychiatric disorders, less success in managing
health behaviors, and higher levels of mortality in adults aged 60 years or older (Batty,
Deary, & Macintyre, 2007; Batty, Deary, Schoon, & Gale, 2007a; Deary, Weiss, & Batty,
2010; Sachs et al., 2011). Cognition and intelligence may also contribute to higher levels
of systemic inflammation, which can influence the development of chronic diseases and
increase one’s risk for stroke, heart attack, and mortality (Franceschi et al., 2000; Harris
et al., 1999; Newman et al., 2009; Segerstrom, Reed, & Scott, 2017).
Segerstrom, Reed, and Scott (2017) investigated the relationship between
intelligence and systemic inflammation, measured using interleukin-6 (IL-6), a proinflammatory cytokine. Specifically, they explored the role that repetitive thought (RT)
may have in this established relationship. The 120-participant, longitudinal study of older
adults (Mage = 74 years, MIQ = 113), initially found that higher IQ predicted lower levels
of IL-6 and that the total amount that one engages in RT (total RT) mediated this
relationship. However, they also found that the amount one engaged in RT did not predict
systemic inflammation in individuals with high IQ, but that more engagement in RT did
predict lower levels of systemic inflammation in individuals with an average IQ; thus, IQ
also moderated the relationship between total RT and systemic inflammation.
A replication of this finding could corroborate the results and expand upon what
was found using a larger, more diverse sample with additional markers of systemic
inflammation. Segerstrom and colleagues (2017) studied an aging population with a high
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mean IQ (M = 113); a replication study focusing on a larger age range and closer-toaverage IQ would increase generalizability.
In addition, Segerstrom and colleagues (2017) measured RT at the trait level,
which provided a limited picture of day-to-day RT and its potential effects. Although
collecting data on RT at the trait level is convenient, there are risks associated with
measuring any construct retrospectively, including the biases that may skew one’s
memory and reporting of such events or feelings (Brown & Harris, 1978; Thompson,
Skowronski, Larsen, & Betz, 2013). Additionally, there is evidence of lack of
correspondence between retrospective and daily diary data collection. Stone and
colleagues (1998) found that 30% of participants were not able to accurately recall what
they had endorsed previously on ecological momentary assessments of coping. A daily
measure of RT would provide a different, and potentially more accurate, representation of
daily RT for each participant.
Lastly, Segerstrom and colleagues (2017) operationalized systemic inflammation
as serum IL-6. Additional pro-inflammatory biomarkers would provide a more
comprehensive understanding regarding the role of IQ and RT on systemic inflammation.
The aim of this study was to replicate the findings of Segerstrom and colleagues
(2017), that IQ moderates the relationship between RT and systemic inflammation, in a
sample of larger age range, closer-to-average IQ range, and with additional proinflammatory biomarkers: C-reactive protein (CRP) and tumor necrosis factor alpha
(TNF-a).
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Systemic Inflammation and Cognition
Inflammation can be an acute and beneficial immune response to sites of injury,
invasion, or infection (Segerstrom & Miller, 2004). However, under situations of stress,
aging, or illness, systemic levels of inflammation can increase, leading to possible tissue
damage, degeneration, and dysfunction of the immune system (Franceschi et al., 2000;
Franceschi & Campisi, 2014; Segerstrom & Miller, 2004). Individuals whose bodies
remain at low-grade, chronic states of inflammation may be at higher risk for negative
health consequences such as schizophrenia, Parkinson’s disease, Alzheimer’s disease,
and multiple sclerosis, and older individuals may be at a higher risk of morbidity and
mortality (Franceschi et al., 2000; Stolp & Dziegielewska, 2009).
IL-6, CRP, and TNF-a are commonly studied inflammatory biomarkers because
they are easy to detect, easy to study, and sufficiently studied in prior literature
(Franceschi & Campisi, 2014; Michaud et al., 2013). IL-6, a primarily pro-inflammatory
cytokine involved in specific and nonspecific immune responses, can be induced by
TNF-a, a pro-inflammatory cytokine also found in the central nervous system that works
to induce other cytokines to sites of injury or infection (Ershler & Keller, 2000; see
reviews by Hopkins & Rothwell, 1995; Rothwell & Hopkins, 1995; Yudkin et al., 2000).
IL-6 and TNF-a can regulate the synthesis of CRP, part of the innate immune system
involved in cell death and inducing cytokines to sites of injury and infection (Gabay &
Kushner, 1999; see review by Yudkin et al., 2000).
Systemic inflammation may be predicted and affected by cognitive deficits and
decline. Decline of global cognition and executive function were related to elevated
levels of IL-6 and CRP (IL-6, r = 0.56; CRP, r = 0.53, and IL-6, r = 0.54; CRP, r = 0.54,
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respectively), even after adjusting for socioeconomic status, depression, and other clinical
conditions (Kuo et al., 2005; Schram et al., 2007; Tegeler et al., 2016). In 500 middleaged adults, worse short-term memory, verbal and mathematical reasoning, vocabulary,
and verbal fluency were related to higher IL-6; after controlling for age, gender, race, and
education, poorer performance on auditory recognition tasks (b = 0.12, r = 0.13) and
working memory (b = 0.13, r = 0.14) remained significantly related to elevated levels of
IL-6 (Marsland et al., 2006). A similar relationship was found for CRP: decline in
vocabulary with age, poorer performance on tasks of short-term memory, verbal fluency,
verbal and mathematical reasoning, and vocabulary were related to elevated levels of
CRP in older males, with the latter two remaining significant in the adjusted model (OR =
1.38 and OR = 1.52) (Gimeno, Marmot, & Singh-Manoux, 2008). In a longitudinal study
with 1,352 participants, poorer visual organization (b = -0.06) and Boston Naming Test
performance (b = -0.02) (Jefferson et al., 2011) was related to higher CRP. Further,
poorer reading performance after 6.3 years (b = -0.68), as well as visual organization (b
= -0.11), visual attention and task switching (b = 0.04), and similarities (b = -0.08) were
related to higher levels of TNF-a at baseline (Jefferson et al., 2011). Increased rate of
cognitive decline in individuals with Alzheimer’s disease and in healthy adults may also
be associated with higher levels of TNF-a (Bruunsgaard et al., 1999; Holmes et al.,
2009). Studying cognition and immune function across the lifespan is important for a
comprehensive understanding of how the mind effects the body (Batty, Deary, &
Macintyre, 2007; Batty, Deary, Schoon, Gale, 2007; Calvin, Batty, Lowe, & Deary,
2011).
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Repetitive Thought
RT is defined as the “process of thinking attentively, repetitively, or frequently
about oneself and one’s world” (Segerstrom, Stanton, Alden, & Shortridge, 2003, p. 909).
Discrete forms of RT include worry, rumination, and depressive rumination, as well as
reflecting, processing, and planning. Across forms, RT qualities are subsumed under
three orthogonal dimensions: Valence (positive vs. negative content), Purpose (searching,
uncertain, or questioning vs. solving, certain, or affirming), and Total RT (the total
amount of RT across all forms) (Segerstrom et al., 2003, 2010).
Among older adults, total RT has been found to be associated with higher IQ (r =
0.26) and more perceived growth following trauma (Segerstrom, Roach, Evans, Schipper,
& Darville, 2010; Segerstrom, Eisenlohr-Moul, Evans, & Ram, 2015). Although total RT
was previously found to mediate the relationship between IQ and systemic inflammation,
RT valence and RT purpose did not (Segerstrom et al., 2017). Further, in subsequent
analyses, total RT significantly interacted with IQ, but RT valence and RT purpose did
not.
Despite these null findings, there is evidence that RT valence may have some
health consequences. Negative RT has associated with maladaptive health outcomes,
including higher depression and anxiety, poorer subjective health, lower number of
natural killer cells, a higher cortisol awakening response, higher risk for coronary heart
disease and angina pectoris, and higher resting blood pressure (Basevitz, Pushkar,
Chaikelson, Conway, & Dalton, 2008; Chambers & Davidson, 2000; Harrington &
Blankenship, 2002; Kubzansky et al., 1997; Segerstrom, Glover, Craske, Fahey, 1999;
Segerstrom, Solomon, Kemeny, & Fahey, 1998; Segerstrom, Tsao, Alden, & Craske,
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2000). Alternatively, some individuals engage in positive RT through which they can
work through, make sense of, and integrate the experience into their beliefs about the
world (Watkins, 2008). Positive RT has not been investigated as extensively as negative
RT, but there is evidence to suggest that it may lead to more adaptive health outcomes.
Positive RT has associated with more posttraumatic growth, as have cognitive rehearsal
and processing 3 months later in cancer patients (Calhoun et al., 2000; Salsman,
Segerstrom, Brechting, Carlson, & Andrykowski, 2009). Trait-level reflection has also
predicted lower levels of IL-6 (Woody, Figueroa, Benencia, & Zoccola, 2016). Although
RT valence did not moderate the relationship between IQ and systemic inflammation or
interact with IQ in the study by Segerstrom and colleagues (2017), these findings suggest
that further exploration of RT valence effects would be meaningful.
The Present Study
The purpose of this study was to replicate and extend the findings of Segerstrom
and colleagues (2017). The first aim of this study was to test if the interaction between
total RT and cognition (measured as IQ via the North American Adult Reading Test in
Segerstrom et al., 2017 and as cognition via the Brief Test of Adult Cognition in the
present study), predicts systemic inflammation, thus indicating that cognition moderates
the RT-systemic inflammation relationship. The second aim included exploring whether
RT valence interacts with cognition, indicating that cognition moderates the RT-systemic
inflammation relationship. Lastly, any relationships that did not depend on cognition
were tested in mediational models to see if cognition exists as a mechanism by which the
relationship between RT and systemic inflammation exists. The study tested the
following hypotheses:
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1. Higher levels of cognition will be related to lower levels of an inflammatory
marker composite. Bonferroni-adjusted post-hoc analyses tested correlations
with each inflammatory marker.
2. Individuals who engage in more total RT at lower levels of cognition will
have lower levels of systemic inflammation, but lower levels of systemic
inflammation are expected for individuals at higher levels of cognition
regardless of the amount they engage in RT; thus, the relationship between RT
and systemic inflammation will be moderated by cognition. Secondary,
exploratory analyses included testing the same hypothesis with RT valence in
place of total RT, such that individuals who engage in more positive RT at
lower levels of cognition will have lower levels of systemic inflammation, but
that those at higher levels of cognition will have lower levels of inflammation
regardless of their RT valence. Bonferroni-adjusted post-hoc analyses were
performed to investigate each inflammatory marker individually.
3. If hypothesis 2 is not supported, total RT and RT valence were tested in a
mediation model. In that case, the following was expected based on previous
findings of Segerstrom and colleagues (2017): Individuals with higher levels
of cognition will report more total RT and/or more positively valenced RT,
which will be associated with lower systemic inflammation. Bonferroniadjusted post-hoc analyses were performed to investigate each inflammatory
marker individually.
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CHAPTER TWO: METHODS
Participants
The participants for the proposed study were drawn from de-identified
participants of the Midlife in the United States (MIDUS) Refresher Project, collected
between 2011 and 2014, which studies health and well-being in middle-aged adults. The
MIDUS project was approved by the University of Wisconsin Institutional Review Board
and follows national, local, and global regulations (Ryff et al., 2011-2014). Participants
were selected by random digit dialing to landlines and cellphones to individuals who
were noninstitutionalized, English-speaking adults in the United States (Ryff et al., 20112014).
Of the possible 3,577 participants who completed the initial MIDUS telephone
interview and mail-in questionnaire, 225 participants completed the cognitive task over
the phone, had IL-6, CRP, and TNF-a collected via blood draw, and completed the daily
diary study, where they indicated at least one positive and one negative event during the
8-day diary. In total, 40 participants were excluded based on the following criteria:
current smokers of cigarettes, cigars, pipes, use of chewing tobacco or snuff; current
chemotherapy or radiation treatment; current pregnancy; a diagnosis of tuberculosis,
thyroid disease, AIDS/HIV, or lupus/autoimmune disease; or use of opioids.
Additionally, 32 participants were excluded for use of the following drugs:
immunosuppressant, systemic steroids, cytotoxic drugs, TNF-a blockers, or use of more
than two of the following: a or b blockers or ACE inhibitors, hormone replacement,
thyroid supplements, or antidepressants, anxiolytic, hypnotics, or antipsychotics. These
exclusion criteria matched that of the original study (Segerstrom et al., 2017).
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The final sample consisted of 153 adults, ranging in age from 25-70 years old (M =
45.07, SD = 10.96). The participants were 50.3% female, 71.2% married, and 83%
White/Caucasian. See Table 1 for full report of descriptive statistics.
A power analysis was conducted using G*Power 3.1 to determine the minimum
effect size that may be found given a sample size of N = 153, a-error probability = 0.05,
and 80% power. The final sample would be sufficient to achieve 80% power to detect a
small-to-moderate effect size of h2 = 0.049. Segerstrom and colleagues (2017) found a
similar effect size, h2 = 0.056, in their moderation model that found that the interaction
between IQ and total RT predicted IL-6; thus, the current sample should be able to
sufficiently replicate the findings of the previous study.
Table 1. Descriptive Statistics
Mean (SD)
Gender (%)
Female
Male
Race (%)
White
Black/African American
Native American/Alaska
Native
Asian
Other
Age
Body Mass Index
Marital Status (%)
Married
Separated
Divorced
Widowed
Never Married
Biomarker Data Collection Site (%)
UCLA
UW
Georgetown

50.3
49.7

Minimum Maximum Skewness
-

-

-

-

-

-

25

70

.161

19.41

77.58

2.363

-

-

-

-

-

-

83
6.5
1.3
1.3
7.8
45.07
(10.96)
28.83
(7.57)
71.2
1.3
10.5
3.3
13.7
34
31.4
34.6
9

Measures
Measures were administered as part of a larger battery associated with the
MIDUS Refresher Project.
Demographics: Participants provided demographic information during an initial
45-minute telephone interview and a 108-page mail questionnaire. Data were collected
November 2011 – September 2014. Relevant demographic information includes age,
gender, race/ethnicity, BMI, and marital status.
Cognition: Cognition was assessed for 20 minutes over the phone with the Brief
Test of Adult Cognition by Telephone (BTACT) following the completion of the initial
telephone interview and mail questionnaire. Cognition data were collected between
February 2012 – September 2014 (Lachman, 2011-2014). The BTACT includes seven
facets: Word List Recall, Digit Span Backward, Category Fluency, Red/Green Task,
Number Series, Backward Counting, and Short-Delay Word List Recall (Ryff &
Lachman, 2011-2014; Lachman, Agrigoroaei, Tun, & Weaver, 2014). In prior study of 84
healthy adults ranging from 23 to 80 years old, the BTACT had high internal consistency
(a = 0.82). A factor analysis of the seven facets of the measure found that five of the
seven tasks loaded onto executive functioning; factor loadings ranged from 0.30 to 0.88
(Lachman, Agrigoroaei, Tun, & Weaver, 2014). For this reason, this measure is described
as capturing “cognition” rather than “IQ” for this present study. The MIDUS Refresher
project found an internal consistency of a = 0.71 in the sample that completed the
cognitive assessment over the phone (Lachman, 2011-2014).
IL-6, CRP, TNF-a: Biomarker data were collected during a 24-hour hospital stay
at one of three sites (UCLA, University of Wisconsin, and Georgetown University)
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between October 2012 and August 2016. Participants were eligible to participate in the
biomarker project following completion of the initial telephone interview and mail
questionnaire (Weinstein, Ryff, & Seeman, 2012-2016). IL-6, CRP and TNF-a were
assessed via fasted blood draws on Day 2 of the 24-hour hospital stay. IL-6 was measured
using the Quantikine High-sensitivity ELISA kit (assay range: 0.156-10 pg/mL; interassay CV: 15.66%; intra-assay CV: 3.73%) at MIDUS BioCore Laboratory (University
of Wisconsin, Madison, WI). TNF-a was measured by
immunoelectrochemiluminescence using a V-plex Custom Human Cytokine Kit (assay
range: 0.69-248 pg/mL; inter-assay CV: 7%; intra-assay CV: 3.19%) at MIDUS BioCore
Laboratory (University of Wisconsin, Madison, WI). CRP was initially measured in
plasma by a BNII nephelometer (assay range: 0.164-800 µg/mL; inter-assay CV: 1.08 4.3%; intra-assay CV: 2.3 - 4.4%). Samples with very low levels of this biomarker were
re-assayed using a high sensitivity assay (immunoelectrochemiluminescence). In the
beginning of 2016, CRP plasma assays were all performed using the high-sensitivity
assay. However, due to “technical difficulties” of assaying plasma in the
immunoelectrochemiluminescence kits, CRP was eventually assayed in serum (assay
range: 0.014-216 µg/mL; inter-assay CV: 4.72 – 5.16%; intra-assay CV: 2.2 – 4.1%;
Blood, Urine, and Saliva Data Documentation, p. C5). Corrections and re-assay of this
data were applied at the MIDUS BioCore Laboratory (University of Wisconsin, Madison,
WI), where: CRP = 0.4906 * (serum MSD value) + 0.1743.
Repetitive Thought: Repetitive thought data were collected as part of the MIDUS
Refresher Daily Diary Project: National Study of Daily Experiences (NSDE) daily diary
over the phone. The NSDE consisted of an 8-day study of self-reported daily experiences
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and their effect on daily living, and 80.2% of daily diary participants completed all eight
days. Data were collected October 2012 - November 2014. Participants were eligible to
participate in the daily diary following completion of the initial telephone interview and
mail questionnaire (Ryff & Almeida, 2012-2014). RT was assessed using the following
questions and their follow-ups. First, participants either responded “yes” or “no” to the
subsequent questions:
Table 2. Negatively and positively valenced questions
Negatively-Valenced Questions:
Positively-Valenced Questions:
Did you have an argument or a
disagreement today?
Did you avoid a disagreement today?
Did anything happen at work or school?
Did anything happen at home?
Did any discrimination happen to you?

Did you have a positive interaction with
someone today?
Did you have a positive experience at
work?
Did you have a positive experience at
home?
Did anything happen to a friend that was
positive for you?
Did anything else positive happen?

Did anything happen to a friend that
stressed you?
Did anything else [negative] happen to
you?
The follow-up questions were not the same for the positively or negatively
questions. If the participant responded “yes” to a positively-valenced questions, they
were prompted with a follow-up question. For negative events, participants were asked
two questions during each daily diary questionnaire. The following questions were used
to quantify positive and negative RT:
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Table 3. Negatively and positively valenced follow-up questions
Negatively-Valenced Question Follow-up:

Positively-Valenced Question Follow-up:

How often have you thought about
How much have you thought about this
personal problems/ concerns?
event?
How often have you thought about
situations that upset you?
The negatively valenced questions were measured on a scale of 0 = “None of the
time” to 4 = “All of the time,” and were strongly correlated (r = .699, p < .001). The
positively valenced questions were measured on a scale of 0 = “Not at all” to 3 = “A lot”.
The mean of the values across the week for each participant was used to define positive
and negative RT. These values were standardized, and total RT was calculated as a sum
of the standardized mean values of negative RT and positive RT per person across all
diaries. RT valence was calculated as the difference of the standardized mean values of
negative RT and positive RT.
Data Analyses
1. The composite score from the BTACT was correlated with an inflammation
composite comprised of the mean of each participant’s standardized values of
IL-6, CRP, and TNF-a.
2. The systemic inflammation composite was individually regressed on the
composite score from the BTACT (cognition) and total RT, centering each
around their sample mean to ensure that zero was an interpretable value. Next,
the systemic inflammation composite was regressed onto cognition and total
RT in one model. Last, the hypothesis that cognition moderates the
relationship between total RT and systemic inflammation was investigated by
regressing the systemic inflammation composite variable on the interaction
between cognition and total RT. Additionally, the secondary hypothesis that
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cognition moderates the relationship between RT valence and systemic
inflammation was investigated by regressing the systemic inflammation
composite on the interaction between cognition and RT valence. Models were
adjusted with centered age and BMI values, and statin use. Post-hoc analyses
to investigate each biomarker individually were conducted by regressing each
individual standardized inflammatory biomarker on the interaction between
cognition and total RT and cognition and RT valence in three separate models.
Lastly, the Bonferroni correction was implemented to control for Type I error.
3. If cognition was found to not moderate the relationship between total RT or
RT valence and systemic inflammation, total RT or RT valence were tested as
mediators between cognition and systemic inflammation. Multiple regression
analyses were performed using the composite score from the BTACT, the
systemic inflammation composite, and the total RT or RT valence variables.
Mediation was determined by the Sobel test and conducted through Preacher’s
PROCESS in SPSS (Preacher & Hayes, 2004; Sobel, 1982). Post-hoc analyses
to investigate each inflammatory biomarker individually was conducted by
regressing each individual standardized biomarker on the mediational model
of cognition and total RT and/or cognition and RT valence in two separate
models. The Bonferroni correction was implemented to control for Type I
error.
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CHAPTER THREE: RESULTS
Descriptive Statistics
Table 4 contains the descriptive statistics and correlations among study variables,
with RT variables averaged within participants. Compared with the larger MIDUS
Refresher sample, this study sample had a higher cognition (M = .509). Of the 153
participants in the present study, 43 had at average or below-MIDUS-average cognition
(M < 0.0). Compared to the overall sample from MIDUS that completed the daily diaries,
the average amount of negative RT for this study sample was lower (M = -.199), but the
average amount of positive RT was higher (M = .073); both were significantly different
compared to the overall MIDUS sample (t = -3.201, p = .002). Although IL-6 and CRP
were correlated (r = .633, p < .01), TNF-a was not significantly related to either
biomarker (r = .138 and r = .141, respectively). Therefore, the Systemic Inflammation
Composite was tested to satisfy planned analyses, but univariate analyses were also
necessary.
Table 4. Descriptive Statistics and Correlations of Study Variables (N = 153)
1. Cognition
2. Age
3. RT Total
4. RT Valence
5. Neg RT

6. Pos RT
Inflammation
Composite
7. TNF-a a
8. CRPa
9. IL-6a
a

Mean (SD)
.509 (.94)
45.07 (10.96)
-.126 (1.0)
-.273 (1.1)
-.120 (.74)
.073 (.73)

2
-.213**

3
-.039
-.089

4
-.137
-.016
.006

5
-.125
-.074
-

.292 (.14)
-.060 (.48)
.143 (.32)

6
.071
-.051
-.029

7
.022
.037
-.046
-.015
-.042
-.021

8
-.052
.106
-.083
.027
-.038
-.078

9
-.161*
.268**
-.069
.042
-.018
-.078

.138

.141
.633**

Note. = log10 transformed values. * p < .05, ** p <.01
Hypothesis 1
Cognition was not significantly related to the systemic inflammation composite (r
= -0.087, p = 0.285). Higher cognition was significantly related to lower levels of IL-6 (r
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= -0.161, p =.046), but this relationship did not withstand Bonferroni correction (a =
.05/4, or 0.0125). Higher IQ was not significantly related to levels of TNF-a or CRP (r =
.022, p = .784; r = -0.052, p = .522).

Hypothesis 2
Neither interaction between cognition and Total RT or cognition and RT Valence
significantly predicted systemic inflammation, as a composite, in the unadjusted model (β
= -0.001, SE = .064, ∆R2 = .000; β = -0.154, SE = .052, ∆R2 = .022). Table 5 contains the
results of the adjusted model, controlling for age, BMI, and statin use. Collectively, age,
BMI, and statin use accounted for 25.2% of the variance in systemic inflammation
(adjusted R2 = .252, Fchange = 18.114, p < .001). In the adjusted models, the interaction
between cognition and RT Valence significantly accounted for 4.8% of the variance in
predicting systemic inflammation (β = -0.230, ∆R2 = .048, Fchange = 10.241, p = .002), but
the interaction between cognition and Total RT did not (β = .070, ∆R2 = .005, Fchange =
.964, p = .328).
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Table 5. Adjusted Multiple Regression for Models Predicting Systemic Inflammation
Composite Variable
Model 1
B(SE)

β

Total RT
Age
.013(.005)
.188*
BMI
.045(.007)
.468
Statin Use
-.284 (.152) -.139
IQ
Total
IQxTotal
∆R2
.267
F Change
18.114
RT Valence
Age
.013(.005)
.188*
BMI
.045(.007)
.468
Statin Use
-.284 (.152) -.139
IQ
Valence
IQxValence
∆R2
.267
F Change
18.114
Note. Bolded results, p < .01; * p < .05

Model 2
B(SE)
β
.013(.005)
.045(.007)
-.286(.152)
.014 (.057)

.192*
.470
-.140
.018

.000
.061
.013(.005)
.045(.007)
-.286(.152)
.014 (.057)

.012(.057)
.045(.007)
-.278(.153)
.012(.057)
-.030(.051)

.013(.005)
.046(.007)
-.295(.153)
.009(.057)
-.037(.050)
.003
.531

Model 4
B(SE)
β

.186*
.468
-.136
.015
-.042

.012(.005)
.046(.007)
-.294(.154)
.016(.057)
-.030(.051)
.056(.057)
.005
.964

.186*
.478
-.144
.020
-.042
.070

.190*
.477
-.144
.011
-.053

.015(.005)
.048(.007)
-.297(.148)
.038(.056)
-.071(.050)
-.144(.045)
.048
10.241

.221
.498
-.146
.049
-.102
-.230

.002
.340
.192*
.470
-.140
.018

.000
.061

Model 3
B(SE)
β

Post-hoc analyses were conducted to investigate whether cognition moderated the
relationship between the RT variables and the individual inflammatory biomarkers. In the
unadjusted models, the interaction between Total RT and cognition did not significantly
predict levels of TNF-a (β = .013), IL-6 (β = -0.019), or CRP (β = .004). Further, the
interaction between RT Valence and cognition did not significantly predict TNF-a (β = 0.078) or IL-6 (β = -0.082). However, for those with higher levels of cognition, more
positive RT was related to lower levels of CRP (β = -0.179, ∆R2 = .03, Fchange = 4.636, p =
.033). In the adjusted models, age, BMI, and statin use accounted for 4.3% of the
variance in TNF-a (adjusted R2 = .043, Fchange = 3.254, p = .023), 25.1% of the variance
in IL-6 (adjusted R2 = .251, Fchange = 17.984, p < .001), and 17.5% of the variance in CRP
(adjusted R2 = .175, Fchange = 11.743, p < .001). The interaction between cognition and
Total RT did not significantly predict levels of TNF-a (β = .055, ∆R2 = .003, Fchange =
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.453), IL-6 (β = .035, ∆R2 = .001, Fchange = .234), or CRP (β = .065, ∆R2 = .004, Fchange =
.747). However, those with higher levels of cognition, and who engaged in more positive
RT, had significantly lower levels of systemic IL-6 (β = -0.161, ∆R2 = .024, Fchange =
4.867, p = .029) and CRP (β = -0.240, ∆R2 = .052, Fchange = 10.097, p = .002) but not
TNF-a (β = -0.103, ∆R2 = .010, Fchange = 1.531, p = .218). See Appendix 1 for a full report
of the adjusted models.
In the fully adjusted model, for individuals with higher than average cognition (1
SD above the mean), more positive RT was significantly associated with lower systemic
inflammation (β = -0.31, p = .004). For individuals with lower than average cognition (1
SD below the mean), more positive RT was not associated with differences in systemic
inflammation (β = .106, p = .21). Similar, significant simple main effects were obtained
for CRP (β = -0.306, p = .007 vs. β = .128, p = .16; see Figure 1); similar but not
statistically significant simple main effects were obtained for IL-6 (β = -.210, p = .054 vs.
β = 0.081, p = .35; see Figure 2). As expected, there were not significant simple main
effects of RT valence at either level of IQ on TNF-a (β = -0.164, p = .188 vs. β = .023, p
= .819).
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Figure 1. Simple Main Effect of CRP. Standardized log10 CRP for individuals 1 SD
below and 1 SD above the cognition mean as predicted by more negative RT (-1 SD RT
valence) and high (+1 SD RT valence). Model estimates are shown with their standard
errors. CRP = C-reactive protein; RT = repetitive thought.
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Figure 2. Simple Main Effect of IL-6. Standardized log10 IL-6 for individuals 1 SD below
and 1 SD above the cognition mean as predicted by more negative RT (-1 SD RT
valence) and high (+1 SD RT valence). Model estimates are shown with their standard
errors. CRP = Interleukin-6; RT = repetitive thought.

Hypothesis 3
Total RT was tested as a mediator of the relationship between cognition and the
systemic inflammation composite as well as each individual inflammatory biomarker
because prior analyses revealed that these outcome variables did not depend on the
interaction between cognition and total RT. Barron and Kenny’s (1996) criteria were
used to determine if mediation occurred. However, in both the non-adjusted and adjusted
models, cognition was not correlated with total RT (r = -0.039, p = .629; r = .147, p =
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.516), therefore, criteria for mediation were not met for models including cognition, total
RT and the systemic inflammation composite, TNF-a, IL-6, or CRP.
Additionally, RT valence was tested as a mediator of the relationship between
cognition and TNF-a, however, in both the unadjusted and adjusted models, cognition
was not related to RT valence and therefore criteria for mediation were not met (r = .137,
p = .091; r = .211, p = .148)
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CHAPTER FOUR: DISCUSSION
Driven by the established relationship between cognition and systemic
inflammation, this study aimed to replicate previous findings by Segerstrom, Reed, and
Scott (2017) in a larger, and more diverse sample of adults. Additionally, this studied
aimed to extend the previous findings by looking at an additional facet of RT, valence,
and additional biomarkers, CRP and TNF-a. Consistent with Segerstrom and colleagues
(2017), individuals with higher cognition had lower levels of IL-6 but not the other
biomarkers or the systemic inflammation composite. Further, although cognition
consistently moderated the relationship between RT valence and systemic inflammation,
it did not moderate effects of RT total and systemic inflammation. There was a
significant simple main effect of cognition suggesting that individuals with higher levels
of cognition, and whose thought content is more positive, have lower levels of
biomarkers that are common prognostic indicators for chronic, systemic inflammation
and, in later life, inflammaging.
Unlike the previous study, total RT did not interact with cognition in a way that
significantly predicted systemic inflammation. However, the previous findings were
extended in that IL-6 and CRP were predicted by the interaction between cognition and
RT valence, even after controlling for age, BMI, and statin use. There was minimal
overlap in the age range of this study (range= 25-70) compared to the previous study
(range = 60-93), suggesting that RT may serve different purposes at different stages in
life; in older adults, the facet of RT important for better health outcomes, may not be
whether or not an individual has more positive thoughts, but instead that engage in more
thinking overall. Additionally, the discrepancy in findings may be due to
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measuring/capturing IQ and cognition with different measures, which can be a common
problem in replication work (Open Science Collaboration, 2015).
The BTACT includes measures that load heavily onto executive function (EF),
including Digit Span Backward, Category Fluency, Red/Green Task, Number Series,
Backward Counting (Ryff & Lachman, 2011-2014; Lachman, Agrigoroaei, Tun, &
Weaver, 2014), suggesting that the BTACT may capture executive functioning and fluid
intelligence more precisely than generalized intelligence or IQ. Previous literature
suggests that fluid intelligence is closely related to EF and that poorer EF may be related
to any individual’s propensity to engage in more negative RT (Blair & Spreen, 1989;
Segerstrom et al., 2010). Alternatively, Segerstrom and colleagues (2017) used the North
American Adult Reading Test to capture IQ, which reflects crystallized intelligence,
rather than fluid intelligence or EF. It may be that two cognitive processing are
functioning simultaneously: valence of thought content may be interacting with EF and
fluid intelligence versus total RT interacting with crystallized intelligence to separately
effect circulating levels of systemic inflammation. However, correlations in this study
between cognition and RT valence were small and not statistically significant (r = -0.137,
p = .091).
Segerstrom and colleagues (2017) suggested that older adults with an IQ = 103,
may benefit from engaging in more RT to protect themselves from future health
outcomes related to higher systemic inflammation. Alternatively, this study found a
simple main effect of cognition that suggests that individuals with a higher cognitive
capacity (+1 SD) had lower levels of systemic inflammation if they engaged in more
positive RT. The findings from both studies suggest there are benefits of more positive
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RT for individuals functioning at a higher level of cognition and more total RT for
individuals functioning at an average level of cognition (based on the IQ mean in the
previous sample). This may be related to other positive health behaviors and subsequent
outcomes experienced by individuals with higher levels of cognition or because
individuals with higher levels of cognition have a better capacity with which to selfregulate themselves (Hofmann, Schmeichel, & Baddeley, 2012; Scheier & Carver, 1987).
Treatment or simple self-regulatory skills involving cognitive restructuring or “thinking
positively” may be beneficial for individuals with a higher than average level of
cognition in helping to work against inflammaging before its onset. On the other hand,
these findings may not be generalizable to the half of the general population who function
at average to lower-than-average levels of cognition. Future research should investigate
the role the RT may have in effecting levels of systemic inflammation, and thus aging
and other health outcomes, as it relates to lower levels of cognitive functioning.
This study was not without limitations. Whereas Segerstrom and colleagues
(2017) collected data longitudinally, the MIDUS dataset provides single timepoint
collections of all survey, cognitive, and biomarker data. Additional data points could
have provided more reliable measures of biomarkers and cognition over time. Further, a
more precise measurement of IQ through MIDUS would have provided a closer
comparison between results. Although the NSDE asked “How much have you thought
about this event” following each question about positive events, this was not mirrored
following questions about negative events. A more direct comparison between reactions
to positive and negative events may have allowed for RT to be captured more precisely.
Lastly, despite a possible N = 3,577, there were only 153 adults who completed the
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MIDUS survey, cognitive test, National Study of Daily Experiences, and physiological
data collection that met our inclusion criteria. A larger N would have allowed for findings
with more power.
Future research in this area should investigate the relationship between EF, fluid
intelligence, and RT valence to better understand how one’s mental abilities affect one’s
propensity to think positively about their world and potentially experience better future
health effects. Additionally, findings in this area could help influence future treatment or
skills for those who worry or ruminate to the point of dysfunction or impairment. Lastly,
the third facet of RT, purpose, should be investigated to assess the role it may play in
protecting against poor future health outcomes.
Overall, this study provides evidence to suggest that a more positively-focused
content of RT in middle age may lead to lower levels of systemic inflammation in
individuals with a higher level of cognition. In turn, this effect may help protect against
future negative effects that chronic, systemic inflammation has on the aging immune
system and overall functioning.
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Appendix. Adjusted Multiple Regression for Moderation Models Predicting Individual
Biomarker Variables
TNF-a
Total RT
Age
BMI
Statin Use
Cognition
Total
CogxTotal
∆R2
F Change
RT Valence
Age
BMI
Statin Use
Cognition
Valence

Model 1
B(SE)
Β
.008(.008)
.022(.011)
-.549(.234)

.087
.164*
-.197*

.061
3.254*
.008(.008)
.022(.011)
-.549(.234)

Model 2
B(SE)
.009(.008)
.023(.011)
-.556(.235)
.066(.087)

β
.100
.171*
-.199*
.062

.004
.564
.087
.164*
-.197*

.009(.008)
.023(.011)
-.556(.235)
.066(.087)

Model 3
B(SE)
.009(.008)
.023(.011)
-.552(.237)
.064(.088)
-.016(.079)

β

.009(.008)
.024(.011)
-.567(.236)
.059(.088)
-.046(.077)

.009(.008)
.097
.024(.011)
.178*
-.568(.238) -.204*
.069(.088)
.064
-.016(.079)
-.016
.059(.088)
.055
.003
.453

.098
.178*
-.203*
.056
-.048

.010(.008)
.112
.025(.011)
.187*
-.569(.236) -.204*
.077(.089)
.073
-.067(.079)
-.071
-.089(.072)
-.103
.010
1.531
Model 4
B(SE)
β

CogxValence

∆R2
F Change
IL-6
Total RT
Age
BMI
Statin Use
Cognition
Total
CogxTotal
∆R2
F Change
RT Valence
Age
BMI
Statin Use
Cognition
Valence

.061
3.254*
Model 1
B(SE)
.022(.007)
.058(.009)
-.120(.207)

β
.240
.442
-.043

.266
17.984
.022(.007)
.058(.009)
-.120(.207)

.004
.564
Model 2
B(SE)
.021(.007)
.057(.009)
-.115(.208)
-.053(.077)

β
.229
.435
-.041
-.050

.002
.476
.240
.442
-.043

.021(.007)
.057(.009)
-.115
-.053(.077)

.002
.351
Model 3
B(SE)
.021(.007)
.057(.009)
-.108(.209)
-.055(.078)
-.026(.070)

β
.225
.434
-.039
-.052
-.026

.021(.007)
.058(.010)
-.119(.211)
-.053(.078)
-.026(.070)
.038(.078)
.001
.234

.228
.439
-.044
-.054
-.030

.023(.007)
.250
.060(.009)
.453
-.124(.206)
-.044
-.029(.078)
-.027
-.061(.069)
-.065
-.138(.063) -.161*
.024
4.867*
Model 4
B(SE)
β

.001
.135
.229
.435
.208
-.050

.021(.007)
.058(.010)
-.122(.209)
-.057(.078)
-.028(.068)

CogxValence

∆R2
F Change
CRP
Total RT
Age
BMI
Statin Use
Cognition
Total
CogxTotal
∆R2

.266
17.984
Model 1
B(SE)
.008(.007)
.056(.010)
-.184(.218)

.191

β
.087
.423
-.066

.002
.476
Model 2
B(SE)
.008(.007)
.056(.010)
-.187(.218)
.030(.081)

β
.093
.426
-.067
.028

.001
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.001
.170
Model 3
B(SE)
.008(.007)
.056(.010)
-.175(.220)
.026(.082)
-.048(.073)
.002

β

.098
.171*
-.198*
.061
-.016

.000
.040
.100
.171*
-.199*
.062

Model 4
B(SE)

β
.086
.424
-.063
.024
-.049

.008(.007)
.057(.010)
-.194(.221)
.031(.082)
-.048(.073)
.070(.082)
.004

.225
.439
-.042
-.049
-.026
.035

.086
.433
-.070
.029
-.049
.065

F Change
RT Valence
Age
BMI
Statin Use
Cognition
Valence

11.743
.008(.007)
.056(.010)
-.184(.218)

.132
.087
.423
-.066

.008(.007)
.056(.010)
-.187(.218)
.030(.081)

.428
.093
.426
-.067
.028

.008(.007)
.057(.010)
-.196(.220)
.024(.082)
-.035(.072)

CogxValence

∆R2
F Change

.191
11.743

.001
.132

Note. Bolded results, p < .01; * p < .05; Cog = Cognition
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.001
.243

.747
.092
.431
-.070
.023
-.037

.011(.007)
.060(.010)
-.199(.213)
.067(.081)
-.084(.072)
-.206(.065)
.052
10.097

.124
.453
-.071
.062
-.089
-.240
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